MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 184 filers reported holding MYRIAD GENETICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $260,000 | -13.9% | 7,625 | -0.2% | 0.05% | -13.8% |
Q3 2014 | $302,000 | +1.7% | 7,640 | +0.2% | 0.06% | +1.8% |
Q2 2014 | $297,000 | -27.2% | 7,625 | -36.1% | 0.06% | -29.6% |
Q1 2014 | $408,000 | +64.5% | 11,925 | +0.8% | 0.08% | +65.3% |
Q4 2013 | $248,000 | – | 11,825 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 5,000,000 | $98,875,000 | 3.47% |
Tieton Capital Management, LLC | 187,636 | $3,711,000 | 2.72% |
Glenview Capital Management | 3,682,691 | $72,825,000 | 1.67% |
Altium Capital Management LP | 218,650 | $4,324,000 | 1.61% |
S&T BANK/PA | 331,098 | $6,547,000 | 1.18% |
EARNEST PARTNERS LLC | 6,731,429 | $133,114,000 | 0.92% |
DISCIPLINED GROWTH INVESTORS INC /MN | 2,078,075 | $41,094,000 | 0.79% |
SummerHaven Investment Management, LLC | 35,700 | $706,000 | 0.55% |
AIMZ Investment Advisors, LLC | 42,685 | $844,000 | 0.44% |
CONTINENTAL ADVISORS LLC | 36,392 | $720,000 | 0.33% |